Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT03306173 Completed - Clinical trials for Substance-Related Disorders

COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM

Start date: August 8, 2018
Phase: N/A
Study type: Interventional

Early attempts by the tobacco industry to develop "safer" cigarettes led to the widespread introduction of ventilation holes in cigarette filters; however, this design feature may instead increase smoking-related harm and make cigarettes more palatable. The overall goal of this project is to model regulatory restrictions banning cigarette filter ventilation and determine their effects on consumption of both cigarettes and a wide range of alternative tobacco products. Testing potential regulatory actions under controlled conditions will facilitate evidence-based policies that have a net benefit to health.

NCT ID: NCT03301012 Recruiting - Clinical trials for Substance Use Disorders

Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment

SARC-YA
Start date: October 30, 2020
Phase: N/A
Study type: Interventional

At discharge from outpatient treatment, researchers will recruit 300 young adults and randomly assign them to recovery support as usual control condition or the Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) experimental condition. Participants in the experimental conditions will receive a smartphone, a calling/texting/data plan, and the SARC-YA mobile applications for the first 6 months post treatment discharge. Experimental participants will 1) complete a 2-3 minute recovery-focused ecological momentary assessment (EMA) at 5 random times a day, receive feedback on their current answers, and provided access to behavioral charting of their past answers over time; and 2) receive continuous access to a suite of self-initiated ecological momentary interventions (EMI) to support their recovery via tool box of coping tools, apps related to getting support, and apps related to maintaining a healthy lifestyle. Data include standardized assessments, urine tests, mobile phone metadata, EMA responses, and EMI utilization. The study's primary aim and hypothesis are: Aim 1: Test the effects of experimental assignment on the frequency of substance use. H1 Relative to the control group, participants in the experimental group will have lower scores on the quarterly Substance Frequency Scale (3, 6, 9 months post- discharge).

NCT ID: NCT03286218 Completed - Clinical trials for Prescription Drug Abuse (Not Dependent)

A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users

Start date: September 15, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the abuse potential of study drug lasmiditan. Lasmiditan will be compared to a marketed benzodiazepine, alprazolam (positive control), as well as to placebo (dummy substance that looks like lasmiditan or alprazolam without any active drug) to determine the potential for drug abuse. The dosages will be in tablet form and will be taken orally (by mouth). This study will last about 55 days, including screening. Screening will occur within 28 days prior to qualification phase.

NCT ID: NCT03285256 Terminated - Clinical trials for Substance-Related Disorders

Effects of Repeated Memory Training on Memory Function and Addiction Related Processes

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Prospective memory is the ability to implement an intention to the future (e.g. remember to take medication, attend a scheduled meeting), and has receive little attention in addiction. The investigators propose that prospective memory plays a critical, yet unrecognized, role in major human behavior change such as that required in addiction treatment. This study will determine the preliminary efficacy of prospective memory training in improving memory and executive functions while reducing illicit drug use in methadone patients. Participants will be randomly assigned to one of three conditions: an experimental memory training program or one of two comparator memory training programs.

NCT ID: NCT03282890 Completed - HIV/AIDS Clinical Trials

Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs

CHRP-BB
Start date: November 20, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the efficacy and cost-effectiveness of CHRP-BB - an integrated bio-behavioral approach that incorporates the use of PrEP - with an evidence-based behavioral approach aimed at enhancing PrEP adherence and HIV risk reduction among high risk PWUD.

NCT ID: NCT03278496 Completed - Opiate Addiction Clinical Trials

Recovery Housing and Drug Abuse Treatment Outcome

Start date: April 2001
Phase: N/A
Study type: Interventional

Reinforcement-Based Therapy (RBT) is an intensive outpatient substance abuse treatment that includes relapse prevention skills training, goal setting, help with finding employment and abstinence-contingent rent payment for recovery housing in the community. It is meant to provide motivation for continued abstinence while enhancing social stability. In this study, treatment was offered to inner city opiate and cocaine users immediately following a brief medically-supported residential detoxification. Previous research had shown that RBT produces 3- month outcomes superior to those for patients who are referred to outpatient treatment in the community. The present study compared outcomes for patients (N = 243) randomly assigned to receive abstinence-contingent recovery housing with (full RBT) or without additional intensive counseling or to receive usual care referral to outpatient treatment following detoxification. Outcomes were similar at 3- and 6-month follow-ups for those who received recovery housing with (full RBT) and without additional counseling and both these treatments were superior to usual care referral. Study findings support the efficacy of post-detoxification recovery housing with or without counseling for opiate and cocaine users.

NCT ID: NCT03276910 Not yet recruiting - Sports Drug Abuse Clinical Trials

Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents

ERYTHROFER-01
Start date: September 8, 2017
Phase: Phase 1
Study type: Interventional

The main objective of this research is to demonstrate the possible use of erythroferrone (ERFE) as a potential marker of recombinant human erythropoietin (rHuEpo) use to be included in the Athlete Biological Passport (PBA) developed by the World Anti-Doping Agency (WADA).

NCT ID: NCT03264872 Recruiting - Clinical trials for Substance-Related Disorders

Peer MI for Substance-using Emerging Adults

Start date: March 8, 2017
Phase: Phase 2
Study type: Interventional

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Interviewing (PMI) or Waitlist Control (WC).

NCT ID: NCT03260075 Completed - Satisfaction Clinical Trials

Effects of Ward Cats in Patients With Substance Abuse, Depression and Psychosis at UPK Basel

Start date: June 1, 2017
Phase:
Study type: Observational

The aim of this study is to explore the relationship between ward cats and patient satisfaction and stations atmosphere in patients with substance abuse, depression and psychosis. Moreover, we wanted to investigate the patients perception of the ward cats and the relationship between station atmosphere perceived by the employees working wards with and without cat at UKP Basel.

NCT ID: NCT03258905 Completed - Clinical trials for Substance-Related Disorders

Phone App for Grounding

Start date: November 1, 2019
Phase: Phase 2
Study type: Interventional

The goal of this project is to continue to develop a smartphone application ("app") to help youth from ages 18-25 who have a substance abuse problem. The app will engage them in grounding, which is a sensory-based experience to help them feel calm by reducing intense negative feelings and impulses (such as the urge to use a substance or hurt themselves or others).